E’sImmunofluorescenceCells were fixed with 3 paraformaldehyde for 30 minutes, followed by incubation

August 22, 2017

E’sImmunofluorescenceCells were fixed with 3 paraformaldehyde for 30 minutes, followed by incubation with 0.5 Triton X-100 for 5 minutes at room temperature. Nonspecific antibody binding sites were blocked via a 30-minute incubation in PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4; pH = 7.3)Virucidal Nanofiber Textilescontaining 0.25 gelatin and 0.25 bovine serum albumin. Then, the cells were purchase JSI124 incubated for 30 minutes with a specific rat monoclonal antibody directed against the large T antigen (for mouse polyomavirus) or a mouse monoclonal antibody against the polyomavirus VP1 protein produced by recombinant baculovirus (for the baculovirus). Unbound antibody was removed by washing with PBS (3610 minutes), and the cells were then incubated for 30 minutes with a secondary antibody conjugated with Alexa Fluor 488 directed against a rat or mouse immunoglobulin. The cells were finally washed with PBS (3610 1326631 minutes), and cover slips were mounted with glycerol with DAPI. Infected cells werevisualized by fluorescence microscopy using Lucia Software (version 5.1.), Laboratory imaging s.r.o., Prague, Czech Republic.AcknowledgmentsThe authors thank Dr. Jan Sy ora for fluorescence microscopy measurements.Author ContributionsConceived and designed the experiments: JM JF. Performed the experiments: YL PK AM. Analyzed the data: JM JF. Contributed reagents/materials/analysis tools: LP KL. Wrote the paper: JM JF.
The vertebrate MAP1 family of microtubule-associated proteins consists of three members, MAP1A, MAP1B, and MAP1S. MAP1A and MAP1B are .300 kDA proteins and are expressed at high levels in the central and peripheral nervous system in the adult and during development, respectively [1]. MAP1S is smaller (120 kDa) and is ubiquitously expressed [2]. All three proteins share several defining features. They are synthesized as polyprotein precursors and are subsequently cleaved into a heavy and a light chain which bind to each other to form the respective MAP1 complex [1,2]. Heavy and light chains of all MAP1 proteins contain structurally and functionally conserved domains that mediate heavy chain-light chain interaction, microtubule binding, and the potential to interact with F-actin [1?]. The best characterized member of the MAP1 family is MAP1B, a 320-kDa protein which is expressed in the central nervous predominantly during development and in the peripheral nervous system throughout life [1,6]. While originally thought to be expressed mainly in neurons, MAP1B was found to be expressedin Schwann cells [7] and oligodendrocytes [8?0] as well. Consistent with its expression in the nervous system, MAP1B deficient mice display defects in brain development [11?4]. In the peripheral nervous system, MAP1B deficiency results in a reduced number of large myelinated axons, the reduced thickness of myelin sheaths, and a decrease in nerve conduction velocity in the sciatic nerve [13]. In order to elucidate molecular mechanisms that might be involved in the function of MAP1B during development we performed a search for protein interaction partners using one of the domains conserved between MAP1A, MAP1B, and MAP1S as bait. Here we show that the COOH purchase 1113-59-3 terminus of the light chain of MAP1B interacts with a1-syntrophin, a modular adapter protein associated with the dystrophin-glycoprotein complex (DGC) [15?18]. a1-syntrophin, a 58-kD protein highly expressed in the brain, belongs to a multigene family which consists of five isoforms a1, ? and ?, c1 and.E’sImmunofluorescenceCells were fixed with 3 paraformaldehyde for 30 minutes, followed by incubation with 0.5 Triton X-100 for 5 minutes at room temperature. Nonspecific antibody binding sites were blocked via a 30-minute incubation in PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4; pH = 7.3)Virucidal Nanofiber Textilescontaining 0.25 gelatin and 0.25 bovine serum albumin. Then, the cells were incubated for 30 minutes with a specific rat monoclonal antibody directed against the large T antigen (for mouse polyomavirus) or a mouse monoclonal antibody against the polyomavirus VP1 protein produced by recombinant baculovirus (for the baculovirus). Unbound antibody was removed by washing with PBS (3610 minutes), and the cells were then incubated for 30 minutes with a secondary antibody conjugated with Alexa Fluor 488 directed against a rat or mouse immunoglobulin. The cells were finally washed with PBS (3610 1326631 minutes), and cover slips were mounted with glycerol with DAPI. Infected cells werevisualized by fluorescence microscopy using Lucia Software (version 5.1.), Laboratory imaging s.r.o., Prague, Czech Republic.AcknowledgmentsThe authors thank Dr. Jan Sy ora for fluorescence microscopy measurements.Author ContributionsConceived and designed the experiments: JM JF. Performed the experiments: YL PK AM. Analyzed the data: JM JF. Contributed reagents/materials/analysis tools: LP KL. Wrote the paper: JM JF.
The vertebrate MAP1 family of microtubule-associated proteins consists of three members, MAP1A, MAP1B, and MAP1S. MAP1A and MAP1B are .300 kDA proteins and are expressed at high levels in the central and peripheral nervous system in the adult and during development, respectively [1]. MAP1S is smaller (120 kDa) and is ubiquitously expressed [2]. All three proteins share several defining features. They are synthesized as polyprotein precursors and are subsequently cleaved into a heavy and a light chain which bind to each other to form the respective MAP1 complex [1,2]. Heavy and light chains of all MAP1 proteins contain structurally and functionally conserved domains that mediate heavy chain-light chain interaction, microtubule binding, and the potential to interact with F-actin [1?]. The best characterized member of the MAP1 family is MAP1B, a 320-kDa protein which is expressed in the central nervous predominantly during development and in the peripheral nervous system throughout life [1,6]. While originally thought to be expressed mainly in neurons, MAP1B was found to be expressedin Schwann cells [7] and oligodendrocytes [8?0] as well. Consistent with its expression in the nervous system, MAP1B deficient mice display defects in brain development [11?4]. In the peripheral nervous system, MAP1B deficiency results in a reduced number of large myelinated axons, the reduced thickness of myelin sheaths, and a decrease in nerve conduction velocity in the sciatic nerve [13]. In order to elucidate molecular mechanisms that might be involved in the function of MAP1B during development we performed a search for protein interaction partners using one of the domains conserved between MAP1A, MAP1B, and MAP1S as bait. Here we show that the COOH terminus of the light chain of MAP1B interacts with a1-syntrophin, a modular adapter protein associated with the dystrophin-glycoprotein complex (DGC) [15?18]. a1-syntrophin, a 58-kD protein highly expressed in the brain, belongs to a multigene family which consists of five isoforms a1, ? and ?, c1 and.